National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 4) (PB 39 of 2020) (Cth)

PB 39 of 2020

National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 4)

National Health Act 1953

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated 29 April 2020

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 4).

(2)   This Determination may also be cited as PB 39 of 2020.

1. Commencement

This Determination commences on 1 May 2020.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Brexpiprazole

Insert

Brigatinib

[2]     Schedule 1, after item dealing with Umeclidinium

Insert

Upadacitinib